The global telecare market size is estimated to reach USD 6.34 billion by 2030, registering a CAGR of 4.79% from 2025 to 2030, according to a new report by Grand View Research, Inc. Telecare provides services mainly to vulnerable and elderly individuals for immediate contact with someone for help in case of any emergency. In addition, the increasing development of new technology, from telephones to online virtual visits, has shaped the face of modern healthcare services. Thus, technological advancements have played a crucial role in driving the market growth. Innovations, such as wearable devices, remote monitoring systems, and telemedicine platforms, have revolutionized healthcare delivery by enabling real-time health monitoring, virtual consultations, and remote patient management. For instance, in June 2023, Telecare introduced RxPad, Australia's standalone platform for electronic prescriptions.
Designed by clinicians for clinicians, this innovative solution aims to replace traditional paper prescriptions. RxPad is poised to revolutionize healthcare delivery, improving patient experiences and empowering doctors, making consultations more efficient and enjoyable for everyone involved. This innovative device offers the most advanced features in the market. Moreover, the growing aging population is a significant factor propelling market expansion. With the growing aging population, the demand for healthcare services increases, particularly for chronic disease management and elderly care. Telecare offers a viable solution to meet these demands by providing continuous monitoring and support for older adults. It enables elderly patients to live independently while ensuring they receive timely medical attention.
This demographic shift is creating a substantial market for telecare solutions that cater to the specific needs of older individuals, promoting safety, health, and well-being in an aging society. Furthermore, the increasing prevalence of chronic diseases and rising demand for personalized healthcare solutions have propelled the adoption of telecare technologies. Chronic conditions, such as diabetes, hypertension, and heart disease, require continuous monitoring and management, which can be effectively facilitated through remote monitoring solutions. Telecare enables proactive disease management, early detection of complications, and timely interventions, leading to improved patient outcomes and reduced healthcare costs in the long run. The market is poised for continued growth as healthcare stakeholders recognize the transformative potential of remote monitoring and care management solutions in delivering accessible, cost-effective, and patient-centered healthcare services.
Request a free sample copy or view report summary: Telecare Market Report
The remote medication management segment led the market with the largest revenue share of 50.97% in 2024, attributed to several factors, including the aging population, increased prevalence of chronic diseases, development of elderly telecare apps and technological advancements.
The activity monitoring segment is anticipated to grow at the significant CAGR over the forecast period, owing to technological advancements and the increasing demand for improved healthcare access and outcomes.
North America dominated the telecare market with the largest revenue share of 49.13% in 2024, attributed to several factors such as the high penetration of smartphones and the internet, growing awareness among individuals to maintain physical health and the use of remote healthcare services.
Grand View Research has segmented the global telecare market based on type, and region:
Telecare Type Outlook (Revenue, USD Million, 2018 - 2030)
Activity Monitoring
Remote Medication Management
Telecare Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Norway
Sweden
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Telecare Market
Teladoc Health, Inc.
Abbott Laboratories
Johnson and Johnson
AstraZeneca PLC
F. Hoffmann-La Roche Ltd.
Novartis AG
Bristol-Myers Squibb Company
GlaxoSmithKline plc
Merck and Co., Inc.
Pfizer, Inc.
Sanofi
Samsung Electronics Co. Ltd
Qualcomm Technologies, Inc.
Orange
Google (Alphabet), Inc
Allscripts
Airstrip Technologies, Inc.
AT&T
Apple, Inc.
"The quality of research they have done for us has been excellent..."